← Back to headlines
Johnson & Johnson Invests $1 Billion in Cancer Treatment
Pharmaceutical giant Johnson & Johnson has committed $1 billion towards developing treatments for hard-to-treat cancers. This investment aims to advance research and bring new therapies to patients.
10 Jun, 23:00 — 10 Jun, 23:00
Sources
Showing 1 of 1 sources
